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ABSTRACT
Ebolavirus can cause hemorrhagic fever in humans with
a mortality rate of 50%–90%. Currently, no approved
vaccines and antiviral therapies are available. Human
TIM1 is considered as an attachment factor for EBOV,
enhancing viral infection through interaction with PS
located on the viral envelope. However, reasons under-
lying the preferable usage of hTIM-1, but not other PS
binding receptors by ﬁlovirus, remain unknown. We
ﬁrstly demonstrated a direct interaction between hTIM-1
and EBOV GP in vitro and determined the crystal
structures of the Ig V domains of hTIM-1 and hTIM-4. The
binding region in hTIM-1 to EBOV GP was mapped by
chimeras and mutation assays, which were designed
based on structural analysis. Pseudovirion infection
assays performed using hTIM-1 and its homologs as
well as point mutants veriﬁed the location of the GP
binding site and the importance of EBOV GP-hTIM-1
interaction in EBOV cellular entry.
KEYWORDS Ebolavirus, viral entry, glycoprotein,
receptor, interaction
INTRODUCTION
Ebolavirus (EBOV) and Marburgvirus, belonging to the
Filoviridae family, cause hemorrhagic fever during the course
of their infections in humans. Alarmingly, infections caused
by these viruses have a high mortality rate of 50%–90%
(Dolnik et al., 2008). In 2011, human T-cell immunoglobulin
and mucin domain protein 1 (hTIM-1), previously implicated
as a receptor for hepatitis A virus (Silberstein et al., 2003;
Feigelstock et al., 1998; Wang et al., 2014), was reported as
a receptor for EBOV and Marburgvirus (Kondratowicz et al.,
2011). Recent studies indicate that hTIM-1, with some other
but not all phosphatidylserine (PS) binding receptors, func-
tions as a common attachment factor for a range of envel-
oped viruses, including ﬁloviruses, ﬂaviviruses, HIV, etc.,
through direct interaction with PS of the viral envelope (Li
et al., 2014; Moller-Tank et al., 2013; Meertens et al., 2012;
Jemielity et al., 2013). Interestingly, hTIM-1 can mediate
uptake of viruses independent of the glycoproteins (Moller-
Tank et al., 2013; Jemielity et al., 2013; Takada et al., 1997).
However, recently hTIM-1 was shown to interact with NPC1,
a fusion receptor for ﬁlovirus. This interaction was important
for the entry of EBOV into host cell (Côté et al. 2011; Kuroda
et al., 2015), thus raising an important question on whether
hTIM-1 functions as an attachment factor or it is a bona ﬁde
receptor for EBOV.
TIM family proteins exhibit a classical type I membrane
protein structure with an N-terminal immunoglobulin variable
Ig-like (Ig V) domain, a heavily O-linked-glycosylated mucin-
like domain (MLD) and a short C-terminal cytoplasmic tail
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(Freeman et al., 2010). Three human TIM proteins (hTIM-1,
3 and 4) and eight mouse TIM proteins (mTIM 1–8) have
been identiﬁed so far. hTIM-1, 3 and 4 are considered direct
orthologs of mTIM-1, 3 and 4, respectively (Kuchroo et al.,
2003). More importantly, except for mTIM-2, the Ig V
domains of all TIM proteins were predicted to contain a
conserved PS binding site (Santiago et al., 2007). This is
important in context of cellular entry of virus because PS is
exposed on the membranes of various enveloped viruses
and is known to play an important role in mediating viral
entry (Mercer and Helenius, 2008; Soares et al., 2008).
Intriguingly, PS receptor usage by different enveloped viru-
ses for entry into host cells differs signiﬁcantly, which might
reﬂect distinct mechanisms involving additional interactions
between viruses, PS receptors and other host factors
(Moller-Tank et al., 2013; Jemielity et al., 2013). EBOV
preferably utilizes hTIM-1, not other TIM proteins, to mediate
the entry efﬁciently, which suggests that hTIM-1 probably
has a direct or indirect interaction with EBOV glycoprotein
(GP).
The GP of EBOV is composed of a trimer of disulﬁde-
bonded GP1/GP2 heterodimers, which mediates receptor
(s) binding, internalization, penetration and fusion with host-
membranes (Takada et al., 1997; Wool-Lewis and Bates,
1998; Lee et al., 2008). GP1 contains the receptor binding
domain (RBD), which is used to interact with its cellular
receptor(s), while GP2 mediates virus/host membrane
fusion events (Kuhn et al., 2006; Brindley et al., 2007). The
GP is necessary and sufﬁcient to mediate entry of EBOV or
Ebola pseudovirion into plasma of host cells (Hunt et al.,
2012).
Although methods used to study cellular entry of EBOV
that rely on incorporation of Ebola GP onto surrogate viruses
(HIV-1 pseudotypes) renders the study of EBOV entry
easier, these methods do not exclude the possibility of a role
for the PS located on the pseudovirion membrane in the
process of viral entry into host cell. A structural view of the
virus-receptor interaction or at least of the receptor would be
more instructive about whether additional factors are
involved in the attachment step. To clarify the role of hTIM-1
in cellular entry of EBOV, we ﬁrst studied the interaction of
hTIM-1 with GP of EBOV in vitro. We show that the Ig V
domain of hTIM-1, but not other TIM family members,
interacts directly with the GP and more speciﬁcally with the
RBD of EBOV in vitro. Interestingly, the interaction was
moderately inhibited by PS in a dose dependent manner.
Furthermore, we determined the crystal structures of the Ig
V domains of hTIM-1 and hTIM-4. Using the crystal structure
as a guide we designed hTIM1-hTIM4 chimeras and studied
their binding to EBOV GP to map the location of the GP
binding site. Point mutants of hTIM-1 identiﬁed residues
critical for GP-binding. Pseudovirion assays using point
mutants of hTIM-1 conﬁrmed the importance of the interac-
tion interface in EBOV infection.
RESULTS
Preparation and characterization of Ig V domains
of hTIM1, 3 and 4
Ig V domains of hTIM-1, 3 and 4 with a C-terminal 6× His tag
were produced by using bacterial expression system as
inclusion bodies. Ig V domains were successfully recovered
from inclusion bodies by employing a de-naturation and
refolding protocol. The proteins were further puriﬁed by Ni-
NTA afﬁnity chromatography and size exclusion chromatog-
raphy (See “MATERIALS AND METHODS”). SDS-PAGE and
thermal stability analysis as well as PS binding assays veri-
ﬁed that the Ig V domains of hTIM-1, 3 and 4 represent
functional units, with good purities and stabilities (Fig. 1A–C).
Given the importance of oligomeric state in determination of
the signaling mechanism of cell-surface receptors, the solu-
tion behaviors of the hTIM-1, 3 and 4 Ig V domains were
examined. Sedimentation velocity experiments using an
analytical ultra-centrifuge revealed that Ig V domains of hTIM-
1, 3 and 4 existed as a monomer in solution (Fig. 1D).
hTIM-1 Ig V is the only TIM family protein that interacts
with Ebola GP
To explore the potential interactions between TIM family
proteins and EBOV GP in vitro, Ig V domains of mTIM1–4
(purchased from Sino Biological Inc.), hTIM-1, 3, 4 and
recombinant GPs of Ebola (Zaire and Bundibugyo strain)
were prepared (Fig. S1) (See MATERIALS AND METH-
ODS). Results of binding assays performed using SPR
showed that amongst the proteins tested only hTIM-1 Ig V
could bind EBOV GP. To verify the speciﬁcity of the binding,
4 different constructs of EBOV GPs (Zaire GP 1–501, 1–320,
1–308 with a His tag and Bundibugyo GP 1–308 with a Fc
tag) were tested. These constructs of GP presented a simi-
larly high binding afﬁnity of 4.9–26.7 μmol/L for hTIM-1
(Fig. 2A–D). Bundibugyo GP showed the strongest binding
afﬁnity for hTIM-1 Ig V with a dissociation constant (Kd) of
about 4.9 μmol/L, while GP and RBD from Zaire exhibited
similar binding afﬁnities for hTIM-1 Ig V (Fig. 2B–D). Inter-
estingly the interaction between EBOV GP and hTIM-1 Ig V
can be moderately inhibited by PS in a dose dependent
manner. A 100-fold (mol/mol) excess PS in PBST buffer
reduced binding efﬁciency of hTIM-1 to GP by ∼25%
(Fig. 2E), indicating the possibility that the binding sites of
hTIM-1 to GP and PS overlap partially or fully. Deglycosy-
lated RBD showed a ∼50% reduction in binding afﬁnity for
hTIM-1, indicating that glycans on GP participate, but are not
critical for the binding with hTIM-1 (Figs. 2F and S2).
Structures of the Ig V domains of hTIM-1 and hTIM-4
We crystallized the Ig V domains of hTIM-1 and hTIM-4 and
determined the structures at a resolution of 1.3 Å and 2.3 Å,
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respectively, using the molecular replacement method (See
MATERIALS AND METHODS and Table S1). While hTIM-1
has only one molecule in the asymmetric unit, there are eight
molecules of essentially the same structure present in the
asymmetric unit of hTIM-4. The Ig V domains of hTIM-1 and
hTIM-4, exhibit two antiparallel β sheets with the front and
back faces formed by A, G, F, C, C′, C″ and B, E, D strands
respectively (Fig. 3A and 3C). The overall structure closely
mirrors the structure of mTIM-4 bound with PS. A hydrophobic
cleft formed by CC’ and FG loops, located at an equivalent
position in hTIM-1 and hTIM-4 structures represents the
putative PS ligand binding site (Fig. 3C). Residues known to
interact with PS, including WFND (Santiago et al., 2007) of
the FG loop, are conserved among hTIM-1, mTIM-1, hTIM-4
and mTIM-4 (Fig. 3A). The amine group of the Ser residue of
PS interacts with the Asp and the fatty acid moiety of PS is
likely to be stabilized by the hydrophobic side chains of Trp
and Phe (Fig. 3C). While mTIM-2 lacks the WFND motif
(Fig. 3A) and therefore does not bind PS (Santiago et al.,
2007), the aromatic residues, WF, of hTIM-3 and mTIM-3 are
replaced with hydrophobic residues LM and IM, respectively.
These substitutions lower the PS binding afﬁnities of TIM-3
when compared to those of TIM-1 and TIM-4 (Figs. 1C and
3A). A striking structural observation that was conﬁrmed by
sequence analysis indicates that the Ig V domains of hTIM-1
and hTIM-4 share similarity with the N-terminal immunoglob-
ulin-like domain of sialecsialo adhesin 1 (SnD1), hTIM-1 and
hTIM-4 could be superimposed over the structure of SnD1
with an r.m.s. deviation of 2.3 Å and 2.2 Å, respectively,
(Fig. 3B and 3D). This resemblance suggests that hTIM-1 and
hTIM-4 Ig V domains might be able to bind carbohydrates
using a siglec-like sialic acid binding motif. Three conserved
residues (Trp 2, Arg 97 and Trp 106 in Siglec-1) together with
a number of hydrophobic amino acids constitute sialic acid
binding sites in all the siglecs (May et al., 1998). The putative
PS binding clefts of hTIM-1 and hTIM-4 share the second and
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Figure 1. Characterization of recombinant Ig V domains of hTIM-1, hTIM-3 and hTIM-4. (A) SDS-PAGE analysis of Ig V domains
of several human TIM proteins under reducing condition. (B) First derivatives of the ﬂuorescence curves to measure the stability of Ig V
domains of several human TIM proteins. Human TIM Ig V proteins were mixed with Sypro Orange dye and heated to indicated
temperatures. Raw ﬂuorescent signal increased as the dye bound to hydrophobic residues that were exposed from thermally destabilized
proteins. (C) Binding of Ig V domains of several human TIM proteins to PS. Optical density (O.D.) was monitored at 450 nm to detect
binding of human TIM proteins with Ig V domains to PS liposomes immobilized on plastic plates (See MATERIALS AND METHODS).
(D) Analysis of oligomerization state of Ig V domains of several human TIM proteins in solution by sedimentation velocity experiments.
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third (Arg and Trp) residue with siglecs. However the Trp is
replaced by a Phe. Similar to other siglecs, hTIM-1 and hTIM-
4 use hydrophobic residues of the CC’ loop to complete the
binding site (Fig. 3B and 3D). Thus, our structural studies
indicate that in addition to PS, hTIM-1 and hTIM-4 could
possibly bind other ligands; in particular, carbohydrates.
A unique groove adjacent to PS binding site in hTIM-1
Despite sharing overall structural similarities with other Ig V
domains of TIM family proteins, hTIM-1 Ig V domain exhibits
unique features that may be essential for its distinct biolog-
ical roles. Most notably, hTIM-1 possesses a signiﬁcantly
short BC loop that is the most variable structural feature
amongst Ig V domains of the TIM family. In addition the
residues of BC loop carry smaller side chains when com-
pared to other TIM family proteins (Fig. 3A). This structural
feature coupled with the movement of FG loop of hTIM-1
away from the BC loop, creates a unique groove that merges
with the PS binding cleft (Fig. 4). Two residues (Arg 110 and
Arg 86) in hTIM-1 (while the counterparts are Pro and Gly,
respectively in other TIM family members) render the two
walls of the groove positively charged (Fig. 4). To ﬁnd out
why only hTIM-1 but not other TIM proteins bound EBOV GP,
we looked at structures of hTIM-1 homologues. In mTIM-1
structure, as the FG loop moves forward towards the BC
loop, the FG and BC loops are connected by the Pro and Arg
residues, forming a channel (Fig. 4). For hTIM-3, the longer
strands of βC and βG approach to each other, so that the FG
and BC loops are too close to form a groove, whilst, a fully
negatively charged valley is formed by BC loop and C’C’’
loop (Fig. 4). On the contrary, the BC loop of mTIM-3 extends
away from the FG by up to 11.3 Å, leading to a ﬂat and
broader groove with negatively charged decoration on one
side (Fig. 4). As to hTIM-4 and mTIM-4, three extra residues
from the BC loop ﬁll in the gap between the FG and BC loop
(Fig. 4). Thus, the surface characteristics; in particular, the
putative ligand-binding groove of hTIM-1 are different from
those of hTIM-1 homologues. This could possibly explain
why only hTIM-1 and not other TIM proteins bind EBOV GP.
Multiple sites contribute to the binding of hTIM-1
to Ebola GP
Given that hTIM-1 is the sole target among TIM family to
interact with Ebola GP, at least one of three loops (the BC,
CC’ and FG loops) are expected to participate in the inter-
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Figure 2. Surface plasmon resonance assay for characterizing the speciﬁc binding between hTIM-1 and EBOV GP. The
proﬁles shown are as follows (A) Bundibugyo GP (1–308), (B) Zaire GP (1–308), (C) Zaire GP (1–320) and (D) Zaire GP (1–501)
binding to hTIM-1 Ig V. (E) PS inhibited the binding between hTIM-1 and EBOV GP in a dose dependent manner. Response units
were plotted against PS concentrations (See MATERIALS AND METHODS). (F) Binding of deglycosylated Zaire GP (1–320) to hTIM-
1 Ig V. The binding afﬁnities (Kd) values were calculated using a steady-state afﬁnity model produced with BIAcore 3000 analysis
software (BIA evaluation Version 4.1).
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structural analysis between hTIM-1 and other TIM family
proteins (Fig. 4) where the loops are involved in formation of
cavities for ligand binding. A series of chimeras of hTIM-1
that binds EBOV GP and hTIM-4 that does not bind EBOV
GP, where corresponding structural elements were exchan-
ged, were generated to map the region(s) that are important
for Ebola GP binding (Fig. S3 and See MATERIALS AND
METHODS). In the T14 (BC) mutant, for example, the BC
loop of hTIM-1 was replaced with the corresponding region
of hTIM-4. We hypothesized that the binding afﬁnity of EBOV
GP to hTIM-1 would be lowered by replacement of this
important region with the corresponding region from hTIM-4
and vice versa. We produced these chimeric mutants using a
similar strategy as that used for producing hTIM-1 and ver-
iﬁed them as functional units by thermal stability assays
(Fig. S4). The binding afﬁnities of EBOV GP to these chi-
meras were determined by SPR. As expected, the T14 (BC-
CC’-FG) chimera showed the most dramatic loss in binding
activity to GP, whilst the T41 (BC-CC’-FG) chimera restored
the binding activity to GP (Table 1 and Fig. S5). Remarkably,
the T14 (FG) chimera exhibited only a slightly lower afﬁnity
for Ebola GP, while, both the T14 (BC) and T14 (CC’) chi-
meras decreased the binding afﬁnity by 10 folds (Table 1 and
Fig. S5). In agreement with hTIM-1 chimeras, the T41 (BC-
CC’) and T41 (CC’-FG) chimeras gained some ability of
binding to GP, but with a lower afﬁnity of 73 and 208 μmol/L,
respectively (Table 1 and Fig. S5). An interesting observation
coming out of the studies using chimeras was that
exchanging FG loops did not signiﬁcantly reduce the binding
afﬁnity. This can be explained from the fact that except for
Arg110, all other residues of FG loop from hTIM-1 and hTIM-
4 are highly conserved. However, it should be noted that no
signiﬁcant change in binding afﬁnity for FG loop chimeras
does not necessarily mean that FG loop is not critical for
Ebola GP binding. To address this issue, we constructed
point mutants of residues from the FG loop of hTIM-1.
Single Ala substitutions of the 4 residues (W112/A112 or
F113/A113 or N114/A114 or D115/A115) of the FG loop
abolished the binding of hTIM-1 to Ebola GP (Table 1 and
Fig. S5). The results are consistent with that in the case of the
PS binding, all the four residues of WFND of the FG loop have
been shown to be crucial for binding the ligand (Santiago
Figure 3. Sequence alignment of hTIM-1 homologues and overall structures of Ig V domains of hTIM-1 and hTIM-4. (A and B)
Amino acid sequences of hTIM-1, hTIM-3, hTIM-4, mTIM 1-4 Ig V domains and hTIM-1, hTIM-4, sialecsialo adhesin (SnD1),
respectively were aligned with the program Clustal W (Larkin et al. 2007). Cys residues and disulﬁde bonds are marked with green
numbers. (C) Ribbon diagram of hTIM-1 and hTIM-4 Ig V domain structures. β strands are represented in magenta and labelled with
capital characters, α helices and loops are colored in cyan and orange respectively. A cleft responsible for PS binding is marked with
a red box, critical residues for ligand binding are shown as sticks. (D) Structural comparisons of hTIM-1 Ig V with hTIM-4 Ig V and
SnD1 N-terminal Ig-like domain [PDB code: 1OD9] (Zaccai et al., 2003). Binding residues of SnD1 to sialated glycoconjugates and
ligand (BENZ) are shown as sticks. Potential binding residues of hTIM-1 and hTIM-4 to sialated carbohydrates are also represented
as sticks.
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et al., 2007). Two positively charged residues Arg 106 and Lys
117 in hTIM-1, which are conserved in the TIM family, are
speculated to interact with the carboxylate group of the PS or
sialic carbohydrate (Fig. 3C and 3D), while, these two resi-
dues were veriﬁed to play a key role in the interaction with
Ebola GP as well. Single mutation of these two residues
(R106/A106 or K117/A117) decreased binding of hTIM-1 to
Ebola GP by ∼90% and double mutations (R106K117/
A106A117) lost completely the binding ability (Table 1 and
Fig. S5). In addition, the single mutations R86/A86 and R110/
A110, exhibiting 60% and 50% reduction, respectively, in the
binding afﬁnity of hTIM-1 to Ebola GP, conﬁrmed the structural
interpretation that the unique groove in hTIM-1 also partici-
pates in GP binding (Table 1 and Fig. S5). Based on the
above results, we conclude that all the three loops, BC, CC’
and FG, of hTIM-1 together constitute the binding sites to
Ebola GP, of which the residues Arg 106, Trp 112, Phe 113,
Asn 114, Asp 115 and Lys 117 are critically important for
Ebola GP binding, while, the residues Arg 86, Arg 110 have
moderate effects on GP binding.
hTIM-1 mediated Ebola pseudovirus entry integrates
multiple factors
Integration of viral GP into surrogate viruses (VSV or HIV
pseudotypes) has allowed the EBOV entry to be studied in a
biosafety level 2 setting. hTIM-1 was reported to promote
Figure 4. Electrostatic surface features relevant to the cleft for substrate binding. Distribution of charge on the surface of Ig V of
TIM family proteins is shown [PDB code: 2OR8 (Santiago et al., 2007), 2OR7 (Santiago et al., 2007), 2OYP (Cao et al., 2007), 3BI9
(Santiago et al., 2007) and 4QYC (Huang et al., 2015)]. Blue color represents positive charge; red colour, negative. A unique groove
formed by the BC and FG loops of hTIM-1 is indicated by a black arrow. Arg located on the FG loop in hTIM-1 and the equivalent
residue (Pro) in other TIM family members is labelled.
Table 1. Binding afﬁnity measurements of hTIM-1 Ig V mutants
to EBOV GP
Mutation Location Afﬁnity
hTIM-1 – 2.67 × 10−5
R86A DE loop 5.11 × 10−5
R106A F strand 3.92 × 10−4
R110A FG loop 4.95 × 10−5
W112A FG loop –
F113A FG loop –
N114A FG loop 4.01 × 10−4
D115A FG loop 8.65 × 10−3
K117A G strand 1.96 × 10−4
R106A/K117A – –
T14 (BC) – –
T14 (CC’) – –
T14 (FG) – 5.79 × 10−5
T41 (BC-CC’) – 7.32 × 10−5
T41 (CC’-FG) – 2.08 × 10−4
T14 (BC-CC’-FG) – –
T41 (BC-CC’-FG) – 7.24 × 10−5
Binding afﬁnity is assessed by SPR.
“–” means no detectable binding signals.
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some pseudoviruses entry by binding to the PS on the virion
surfaces; in particular, those from the ﬁlovirus, ﬂavivirus and
alphavirus families (Jemielity et al., 2013). Although various
enveloped viruses and pseudoviruses contain PS on their
membrane (Mercer and Helenius, 2008), hTIM-1 is not able
to promote infection of all pseudoviruses (Moller-Tank et al.,
2013), which suggests that mechanisms of cellular entry
differ for different viruses. To compare the ability of TIM
family proteins to mediate EBOV pseudoviruses transduc-
tion systematically, we cloned hTIM-1, hTIM-4, mTIM-1 and
mTIM-4 into pCMV3-SP vector with a ﬂag tag, evaluated the
surface expression of the 4 proteins in 293 T cells using
ﬂow cytometric assay with an anti-ﬂag antibody (See
MATERIALS AND METHODS). Expression levels of hTIM-1,
hTIM-4, mTIM-1 and mTIM-4 on the cell surface were close
by transient transfection of the indicated amounts of a TIM-
expressing plasmid (Fig. 5A), but hTIM-1 enhanced EBOV
pseudovirus entry signiﬁcantly greater than hTIM-4 and
mTIM-4 (>3-fold when transfected with 0.5 μg) (Fig. 5B).
Surprisingly, expression of mTIM-1 did not enhance EBOV
pseudovirus transduction. Together with the fact that hTIM-3
only enhanced EBOV entry very inefﬁciently (Kondratowicz
et al., 2011; Moller-Tank et al., 2013), these indicate that the
efﬁciency of viral entry via interaction of TIM proteins with PS
of the viral membrane is low when compared to the one
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Figure 5. hTIM-1 serves as a dual-attachment receptor for EBOV and identiﬁcation of hTIM-1 Ig V residues that impact EBOV
GP-dependent entry. (A) Surface expression of hTIM-1, hTIM-4, mTIM-1 and mTIM-4 at 48 h following transfection. HEK 293Tcells
were transfected with increasing amounts of TIM expression plasmids or empty plasmids (62.5 ng, 125 ng, 250 ng and 500 ng), the
expressions of TIM proteins were assessed by ﬂow cytometry using anti-ﬂag antibodies. (B) Compare the transduction efﬁciency of
EBOV pseudovirus mediated by hTIM-1, hTIM-4, mTIM-1 and mTIM-4. At 48 h, transduce EBOV pseudovirions into HEK 293Tcells,
which were transfected with a growing amount of a hTIM-1 or hTIM-4 or mTIM-1 or mTIM-4 expression plasmid (62.5 ng, 125 ng, 250
ng and 500 ng). Luminescence signals are expressed as relative light units (RLU). (C) Identiﬁcation of hTIM-1 Ig V residues that
impact EBOV pseudovirion entry. Compare the transduction efﬁciency of EBOV pseudovirions into HEK 293T cells transfected by
hTIM-1 mutant constructs to that with WT hTIM-1. Empty plasmid transfected HEK 293T cells were used as a negative control.
Transduction of VSV pseudovirions into HEK 293T cells is a positive control. Results shown are the mean ± SEM of three
independent experiments for panel (A–C).
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argument is also supported by the fact that EBOV GP-
bearing VP40-GFP VLPs appeared to be internalized much
more efﬁciently than those lacking GP (Jemielity et al.,
2013). Meanwhile, this argument is also consisted with lower
binding afﬁnity of hTIM1 to PS than to GP (Fig. 1E). Previ-
ously PS was reported to block the entry of EBOV into
hTIM1-expressing 293T cells at the concentration of
10 μmol/L (Jemielity et al., 2013), however, the concentration
of hTIM-1 molecules on the hTIM1-expressing 293T cell
surface is 10–100 nmol/L based on the expression level
analysis, it is not surprising that an approximate over
100-fold (mol/mol) excess PS can inhibit EBOV entry at the
cellular level. EBOV entry mediated by hTIM-1 results from a
dual-interaction of viral GP and PS with hTIM-1 receptor.
Consistent with the results of in vitro binding assays per-
formed using puriﬁed recombinant proteins, mutants of
hTIM-1 (R106/A106, W112/A112, F113/A113, N114/A114,
D115/A115, K117/A117 and R106K117/A106A117), with an
equivalent expression level to that of the wild type, lower
deﬁcient in facilitating cellular entry of Ebola pseudovirus
due to the inability of binding of viral PS or GP to the mutant
hTIM-1 receptor (Fig. 5C).
DISCUSSION
There is an increased appreciation that the PS receptors,
such as TIM family proteins, play important roles in viral
infection (Moller-Tank et al., 2013; Jemielity et al., 2013;
Rennert, 2011). A number of lines of evidence indicate that
hTIM-1 enhances infection of a variety of enveloped viruses
by binding to virion-associated PS and does not require viral
entry protein (Moller-Tank et al., 2013; Meertens et al., 2012;
Jemielity et al., 2013), therefore hTIM-1 is generally descri-
bed as an attachment factor. Contrary to this, preferable
usage of hTIM-1, not other PS receptors by ﬁloviruses and
ﬂaviviruses suggests hTIM-1 may not just function to
enhance the attachment of the virion-associated PS to cell
surface. Moreover, structural analysis reporting that the
membrane of ﬂaviviruses are occluded by tightly-arranged
viral glycoproteins further weakens the argument that TIM-1
is an accessory protein that enhances PS-mediated viral
uptake (Zhang et al., 2003a, 2003b). Lastly, hTIM-1 was
recently shown to interact with NPC1 to facilitate EBOV GP-
mediated membrane fusion (Kuroda et al., 2015) and direct
interaction in vitro between hTIM-1 Ig V and NPC1 C-loop
domain was also demonstrated by SPR (data not shown),
suggesting that hTIM-1 might have additional roles and not
function exclusively as an attachment factor for EBOV. In this
context, our studies demonstrating a direct interaction
between hTIM-1, but not other TIM family proteins, and
EBOV GP in vitro by SPR confers a much bigger role on
hTIM-1 in cellular entry of EBOV. We show that hTIM-1 can
act as a dual-attachment receptor to recruit EBOV to cell
surface by interacting directly with GP and the PS on the
viral envelop. Based on our results of in vitro binding afﬁnity
studies and previously reported pseudovirion assays
(Jemielity et al., 2013), the contribution of GP to mediating
EBOV entry appears to be more signiﬁcant than that by PS.
The structures of Ig V domains of hTIM-1 and hTIM-4
reveal presence of a conserved hydrophobic cavity used by
the TIM proteins for binding to PS. The ligand binding site
is characterized by a constrained size of the cavity and the
requirement for both an acidic group and a hydrophobic
group in the ligand (Fig. 3C). Structural comparisons and
amino acids sequence analysis with the N-terminal Ig-like
domain of the Siglec family suggest that sialated glyco-
conjugates with an acidic group at the head and a
hydrophobic group at the tail might constitute new ligands
for hTIM-1/hTIM-4 (Fig. 3B and 3D). Sialic acids are mainly
terminal components of glycans on glycoproteins and these
sialated carbohydrates are involved in numerous cellular
recognition process, such as pathogens adhesion (Kelm
and Schauer, 1997; Schauer and Kamerling, 1995; Angata
and Varki, 2002). EBOV GP was reported to bear sialic
acid residues at the termini of a small fraction of glycans
(Powlesland et al., 2008). These observations coupled with
the results that deglycosylated GP exhibited a ∼50%
reduction in binding afﬁnity to hTIM-1 (Fig. 2F), allow us to
propose that sialated carbohydrates might be additional
ligands of hTIM-1/hTIM-4.
We compared the amino acid sequences and structures
of hTIM-1 with other TIM family proteins, and designed a
series of hTIM-1-hTIM-4 chimeras and mutants to map the
regions of hTIM-1 that are important for EBOV GP binding.
Three key loops (BC, CC’ and FG loops) of hTIM-1 partici-
pate in interaction with EBOV GP (Table 1). Amongst these,
the BC and FG loops in hTIM-1 form an unique groove-like
structure adjacent to the PS binding site, which is in-turn
formed by FG and CC’ loops (Figs. 3C and 4). Additionally,
we further identiﬁed a number of residues on these three
loops, which are critical for the EBOV GP binding (Table 1). It
is interesting to note that the binding site of PS to hTIM-1 is a
subset or continuation of EBOV GP binding site on hTIM-1,
which explains why hTIM-1 binds to GP with a higher afﬁnity
than hTIM-1 binds to PS.
A recent study has concluded that hTIM-1 is not only
involved in ﬁlovirus attachment but it also participates in
efﬁcient membrane fusion through its interaction with NPC1
in late endosomes (Kuroda et al., 2015). Interestingly, we
observed that the afﬁnity between hTIM-1 and EBOV GP
increases as the pH drops to that observed in endosomes
(pH 7.5–5.7) (Fig. S6). It is possible that hTIM-1 acts as a
bridge to facilitate the binding of NPC1 to GP, initializing
conformational changes in GP to trigger membrane fusion.
In summary, we ﬁrstly identiﬁed the direct interaction
between hTIM-1 and EBOV GP in vitro by SPR assay and
solved the structures of the Ig V domains of hTIM-1 and
hTIM-4 by crystallography, then mapped the regions in hTIM-
1 that are important for EBOV GP binding. Inferences gained
from results of our biophysical and biochemical studies have
been veriﬁed by pseudovirion infection assays. Targeting the
hTIM-1-EBOV GP interaction interface to block the binding
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of EBOV GP to hTIM-1 could be a promising strategy for
stalling the attachment step of Ebola virus infection.
MATERIALS AND METHODS
Structure determination
Materials, such as cells and plasmids, and methods for protein
puriﬁcation, crystallization and the PS binding assay can be found in
the Supplementary Materials. Diffraction data sets for hTIM-1 and
hTIM-4 Ig V domains were collected at beam line BL17U and BL19U
of the Shanghai synchrotron facility with the highest resolution being
1.3 Å and 2.3 Å, belonging to space groups of P43212 and P212121,
respectively. Datasets were processed and scaled using the
HKL2000 package (Otwinowski and Minor, 1997). One and eight
protein molecules in an asymmetric unit with a solvent content of
52% and 59% (corresponding to a Matthews coefﬁcient VM= 2.55
and 2.96 Å3 Da-1 (Matthews, 1968)) were found from crystals of
hTIM-1 and hTIM-4, respectively. The initial structure solutions of
hTIM-1 and hTIM-4 were obtained by molecular replacement using
the program Phaser v2.1 (McCoy et al., 2007) with the crystal
structure of mTIM-1 (Protein Data Bank [PDB] entry: 2OR8 (Santi-
ago et al., 2007)) and hTIM-1 respectively as a search template.
Manual model building and reﬁnement were performed using COOT
(Emsley and Cowtan, 2004) and PHENIX (Adams et al., 2010). The
r.m.s. deviations between the eight NCS-related subunits of hTIM-4
are less than 0.12 Å. Chain A from hTIM-4 was selected for following
structural analysis. Structural ﬁgures were drawn with the program
PyMOL (DeLano, 2002).
Flow cytometric assay
For the surface expression of hTIM-1, hTIM-4, mTIM-1 and mTIM-4,
the coding sequences which start from right behind the signal pep-
tide and last to the end were cloned into the pCMV3-SP-N-FLAG
vector. So that the proteins expressed on the cell surface all have a
ﬂag tag linking at the N terminal. The plasmids were transfected into
TIM1 -/- 293T cells using lipofectamine2000 according to the man-
ufacturer’s instructions (Invitrogen). The cells were collected 48 h
after transfection. To measure the expression, cells were stained
with PE anti-ﬂag antibody and with PE rat Ig G2a antibody as neg-
ative control (Biolegend). 7-AAD was used to monitor the dead cells
through binding to the nucleic acid. The data was analyzed using the
Summit v4.3 software.
Surface plasmon resonance assay
The BIAcore experiments were carried out at room temperature
(25°C) using a BIAcore 3000 machine with CM5 chips. For all the
measurements, a PBST buffer consisting of PBS, pH 7.4 and
0.005 % (v/v) Tween-20 was used. The Ebola GP proteins were
immobilized on the chip at about 7000 response units. Gradient
concentrations of human TIM1 and its mutations (0, 0.625, 1.25, 2.5,
5, 10, 20, 40 μmol/L) were then used to ﬂow over the chip surface.
The binding kinetics were analysed with the software BIAevaluation
Version 4.1 using the steady state afﬁnity. To study the effect of the
ligand PS and pH on the binding of hTIM-1 to EBOV GP, the
concentration of hTIM-1 was maintained constant (10 μmol/L). The
concentration of PS was gradually increased (PS: 200 μmol/L,
500 μmol/L, 1 mmol/L, 2 mmol/L) in the binding buffer. Similarly, the
buffer pH was gradually changed from 7.5 to 5.7 in steps of 0.3 units.
The response values were recorded to analyze the changes.
Thermoﬂuor assay
Thermoﬂuor experiments were performed with iCycleriQ Real Time
PCR Detection System (Bio-Rad) instrument. SYPRO orange was
used as ﬂuorescent probe to monitor the denaturation of the proteins.
25 µL reactions were set up in a PCR plate, containing 0.1 mg/mL
each protein, 5× Sypro Orange in pH ranging from 4.0 to 8.4 buffer
solutions and ramped from 20–95°C with ﬂuorescence recorded in
triplicate at 1°C intervals.
Pseudovirion
Pseudovirions bearing Ebola virus GP protein were produced in
293T cells transfected with PNL 4-3 vector containing Luciferase as
a reporter and pcDNA3.1 vector, which contains GP, using lipofec-
tamine2000 according to the manufacturer’s instructions. Pseu-
dovirus-containing culture supernatant was harvested at 48 h post-
transfection and stored at −80°C.
For infection, cells were plated on 96-well plates and incubated at
37°C with serially diluted pseudovirus-containing supernatant to
yield proper level of infection. Supernatants were replaced with fresh
medium after 3 h of incubation post infection by pseudovirus.
Another 48 h is needed to allow for luciferase reporter to expression
and infection levels were assessed by measuring bioluminescence
signals.
Analytical ultracentrifugation
Sedimentation velocity experiments were performed on a Beckman
XL-I analytical ultracentrifuge at 20°C. Protein samples were diluted
with lysis buffer to 400 μL at an A280nm absorption of about 0.8.
Samples were loaded into a conventional double-sector quartz cell
and mounted in a Beckman four-hole An-60 Ti rotor. Data were
collected at 60,000 rpm at a wavelength of 280 nm. Interference
sedimentation coefﬁcient distributions were calculated from the
sedimentation velocity data using the SEDFIT software program
(www.analyticalultracentrifugation.com).
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EBOV, Ebolavirus; GP, glycoprotein; hTIM-1, human T-cell
immunoglobulin and mucin domain protein 1; MLD, mucin-like
domain; RBD, receptor binding domain.
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